BPNT1

gene product
BPNT1, also called bisphosphate 3-prime-nucleotidase, or BPntase, is a member of a magnesium-dependent phosphomonoesterase family. Lithium, a major drug used to treat manic depression, acts as an uncompetitive inhibitor of BPntase. The predicted human protein is 92% identical to mouse BPntase. BPntase's physiologic role in nucleotide metabolism may be regulated by inositol signaling pathways. The inhibition of human BPntase may account for lithium-induced nephrotoxicity. [provided by RefSeq, Jul 2008]
More gene data

Featured antibodies

Antibodies

 

Filters

Knockdown Initiative

Application

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

  or   Clear
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Recommended by provider
Validated in Knockdown Initative
Eligible for validation in KDI
145 antibodies from 20 providers.

Antibody properties

Applications

or Cancel
AntibodyRefsTypeKDWBELICCIPIHCFC
antibodies-online
38 antibodies
Novus Biologicals
8 antibodies
Abnova Corporation
6 antibodies
Abgent
1 antibody
Atlas Antibodies
1 antibody
LifeSpan BioSciences, Inc.
11 antibodies
Proteintech Group
1 antibody
GeneTex
2 antibodies
Invitrogen Antibodies
2 antibodies
Acris Antibodies GmbH
4 antibodies
Everest Biotech
1 antibody
Aviva Systems Biology
3 antibodies
OriGene
2 antibodies
Arigo
1 antibody
United States Biological
52 antibodies
MyBioSource
4 antibodies
Biorbyt
2 antibodies
Sigma-Aldrich
2 antibodies
St John's Laboratory
1 antibody
Creative Diagnostics
3 antibodies